Rulings protect generic drugmakers and overturn data-mining ban

06/23/2011 | New York Times (tiered subscription model), The

The Supreme Court handed down a pair of decisions that represent a significant victory for the pharmaceutical industry. A 5-4 ruling shields generic drugmakers from failure-to-warn lawsuits as long as their product labels are identical to those of brand-name drugmakers. A 6-3 decision strikes down a law in Vermont restricting the collection and sale of prescription-drug data.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA